(Updated - February 10, 2020 9:55 AM EST)

Chardan Capital Markets analyst Gbola Amusa upgraded Adverum Biotechnologies (NASDAQ: ADVM) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Upgrades

Adverum Biotechnologies (ADVM) Prices 9.5M Share Common Offering at $13.75/ShFebruary 12, 2020 5:50 AM